S-5312-119
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Sponsored by Richard Blumenthal (D-CT)
What it does
This bill would direct the CDC to run a research and public education program on youth e-cigarette and emerging tobacco product use, including surveillance, developing cessation guidance for health providers and schools, and continuing funding to state, local, territorial, and tribal health programs. It would authorize $100 million per year in federal funding for fiscal years 2027 through 2031 and require the Secretary of Health and Human Services to publish an implementation strategy within 90 days of enactment.
Who benefits
Youth and young adults who use or are at risk of using e-cigarettes, public health researchers, state and local health departments and tribal organizations receiving CDC cooperative agreement funding, schools and health care providers seeking cessation guidance, and Medicaid/CHIP enrollees who could gain better access to cessation services.
Who is hurt
E-cigarette and emerging tobacco product manufacturers and retailers could face increased regulatory scrutiny and reputational pressure from federal research and public education campaigns, though the bill imposes no direct restrictions on sales or products. Taxpayers fund the $500 million total authorized spending over five years, and other CDC programs could face competition for future appropriations if funding is not fully offset.
Supporters argue
Supporters argue that e-cigarette use among youth remains a significant public health concern, and that better surveillance data, cessation resources, and coordinated public education campaigns are needed to address nicotine addiction among young people. They contend that continuing existing CDC National Tobacco Control Program funding while adding targeted research on emerging products like flavored vapes fills gaps in current federal knowledge and helps schools and health providers respond effectively.
Opponents argue
Opponents argue that the bill creates another federally funded research and messaging bureaucracy without directly restricting youth access to these products, potentially duplicating existing FDA and CDC tobacco control efforts despite the bill's own "no duplication" clause. They contend that $500 million in new authorized spending over five years should be weighed against other funding priorities, and that public education campaigns have historically shown mixed evidence of reducing youth product use.
Constitutional context
This bill raises no significant constitutional questions; it uses Congress's spending power under the Taxing and Spending Clause (Art. I, §8, cl. 1) to fund a CDC research and grant program, an authority well established since the New Deal era and not meaningfully contested by current doctrine.
Checks and balances
Congress would authorize and appropriate funds while delegating implementation authority to the HHS Secretary and CDC Director, with reporting requirements to relevant congressional committees serving as an oversight check.
Historical precedent
This bill builds on the CDC's existing National Tobacco Control Program cooperative agreements, first authorized under prior public health legislation, extending and expanding that funding model to specifically target e-cigarettes and emerging tobacco products.